| |
 |
|
Nitrates as first line treatment for acute left ventricular failure |
| |
|
|
CPAP in acute left ventricular failure |
| |
|
|
NIPPV for acute cardiogenic pulmonary oedema |
| |
|
|
Managing acute pulmonary oedema with high or standard dose nitrate |
| |
 |
|
Does the application of opiates, during an attack of Acute Cardiogenic Pulmonary Oedma, reduce patients' mortality and morbidity? |
| |
|
|
ED Bedside Ultrasound guided volume assessment with IVC diameter |
| |
 |
|
Use of BNP in diagnosis of LVF |
| |
|
|
Is Warfarin anticoagulation indicated in left ventricular dysfunction |
| |
|
|
ACE inhibitors in addition to standard treatments in acute heart failure |
| |
|
|
Massive PE and cardiogenic shock. To thrombolyse or not to thrombolyse, that is the question. |
| |
|
|
Intubation and NIPPV in heart failure |
| |
|
|
Use of nitrates, opiates and diuretics in heart failure |
| |
|
|
Use of diuretics and ace-inhibitors in heart failure |
| |
|
|
Use of diuretics and nitrates in acute heart failure |
| |
|
|
Use of nitrates and ace-inhibitors in heart failure |
| |
|
|
Pregnancy-associated plasma protein A (PAPP-A): a novel cardiac marker with promise |
| |
|
|
E-selectin as a plasma marker of acute coronary syndromes |
| |
|
|
Soluble ICAM-1 as a cardiac biomarker for use in the Emergency Department |
| |
|
|
Soluble VCAM-1 as a cardiac marker in the Emergency Department |
| |
|
|
C reactive protein in the differential diagnosis of heart failure and chest infection |
| |
|
|
Are troponin levels indicated for the routine management of SVT? |
